Moderna (MRNA) Insider Trading & Ownership $41.11 +2.86 (+7.48%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Moderna (NASDAQ:MRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$81.36 M Get MRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Moderna stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRNA Insider Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Moderna Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/7/2024James M MockCFOSell715$60.12$42,985.80 9/3/2024Shannon Thyme KlingerInsiderSell114$76.99$8,776.86 9/3/2024Stephen HogePresidentSell318$76.99$24,482.82 8/29/2024Shannon Thyme KlingerInsiderSell162$78.03$12,640.86 8/29/2024Stephen HogePresidentSell300$78.03$23,409.00 8/28/2024James M MockCFOSell1,321$79.39$104,874.19 New post-election stock warning from Wall Street (Ad)If you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first time in history...Not everything is as rosy as it seems on Wall Street.8/12/2024Stephen HogePresidentSell254$84.10$21,361.40 7/31/2024Noubar AfeyanDirectorSell15,000$119.96$1,799,400.00 7/24/2024Noubar AfeyanDirectorSell15,000$117.80$1,767,000.00 7/17/2024Noubar AfeyanDirectorSell15,000$122.84$1,842,600.00 7/15/2024Stephen HogePresidentSell15,000$121.12$1,816,800.00 7/10/2024Noubar AfeyanDirectorSell15,000$117.08$1,756,200.00 7/8/2024James M MockCFOSell689$118.24$81,467.36 6/26/2024Noubar AfeyanDirectorSell15,000$127.22$1,908,300.00 6/17/2024Stephen HogePresidentSell15,000$138.16$2,072,400.00 6/11/2024Noubar AfeyanDirectorSell202,832$148.34$30,088,098.88 6/10/2024Shannon Thyme KlingerInsiderSell5,178$148.09$766,810.02 6/5/2024Noubar AfeyanDirectorSell15,000$151.25$2,268,750.00 5/29/2024Noubar AfeyanDirectorSell20,000$145.08$2,901,600.00 5/29/2024Stephen HogePresidentSell341$144.50$49,274.50 5/28/2024James M MockCFOSell648$162.47$105,280.56 5/28/2024Shannon Thyme KlingerInsiderSell1,296$162.47$210,561.12 5/22/2024Noubar AfeyanDirectorSell15,000$157.57$2,363,550.00 5/15/2024Noubar AfeyanDirectorSell15,000$127.32$1,909,800.00 5/10/2024Stephen HogePresidentSell255$120.96$30,844.80 5/8/2024Noubar AfeyanDirectorSell15,000$121.68$1,825,200.00 5/1/2024Noubar AfeyanDirectorSell15,000$110.92$1,663,800.00 4/24/2024Noubar AfeyanDirectorSell15,000$108.32$1,624,800.00 4/17/2024Noubar AfeyanDirectorSell15,000$103.38$1,550,700.00 4/15/2024Stephen HogePresidentSell15,000$105.02$1,575,300.00 4/10/2024Noubar AfeyanDirectorSell15,000$107.12$1,606,800.00 4/8/2024James M MockCFOSell705$101.93$71,860.65 4/3/2024Noubar AfeyanDirectorSell15,000$101.68$1,525,200.00 3/27/2024Noubar AfeyanDirectorSell15,000$109.06$1,635,900.00 3/20/2024Noubar AfeyanDirectorSell15,000$102.39$1,535,850.00 3/13/2024Noubar AfeyanDirectorSell15,000$108.54$1,628,100.00 3/8/2024Shannon Thyme KlingerInsiderSell544$99.05$53,883.20 2/29/2024James M MockCFOSell647$94.57$61,186.79 2/29/2024Shannon Thyme KlingerInsiderSell670$94.57$63,361.90 2/29/2024Stephen HogePresidentSell2,388$94.57$225,833.16 Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW2/1/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$99.02$1,001 - $15,0001/16/2024Stephen HogePresidentSell15,000$103.90$1,558,500.00 1/8/2024James M MockCFOSell772$109.75$84,727.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 12/8/2023Shannon Thyme KlingerInsiderSell563$79.09$44,527.67 12/6/2023Arpa GarayInsiderSell564$78.34$44,183.76 (Data available from 1/1/2013 forward) MRNA Insider Trading Activity - Frequently Asked Questions Who is on Moderna's Insider Roster? The list of insiders at Moderna includes Arpa Garay, David W Meline, James M Mock, Juan Andres, Noubar Afeyan, Shannon Thyme Klinger, Stephane Bancel, and Stephen Hoge. Learn more on insiders at MRNA. What percentage of Moderna stock is owned by insiders? 15.70% of Moderna stock is owned by insiders. Learn more on MRNA's insider holdings. Which Moderna insiders have been selling company stock? The following insiders have sold MRNA shares in the last 24 months: Arpa Garay ($44,183.76), James M Mock ($845,327.35), Juan Andres ($1,605,213.20), Noubar Afeyan ($119,583,448.88), Shannon Thyme Klinger ($1,389,442.45), Stephane Bancel ($154,173,262.65), and Stephen Hoge ($24,045,640.93). How much insider selling is happening at Moderna? Insiders have sold a total of 2,132,429 Moderna shares in the last 24 months for a total of $301,686,519.22 sold. Which members of congress are trading Moderna? Josh Gottheimer (D-NJ) has sold shares of Moderna in the last year totaling $8,000. Moderna Key ExecutivesMr. Stephane Bancel (Age 51)Chief Executive Officer Compensation: $4.55MDr. Stephen Hoge M.D. (Age 47)President Compensation: $1.92MMr. James M. Mock (Age 47)Chief Financial Officer Compensation: $1.4M4 recent tradesMs. Shannon Thyme Klinger (Age 53)Chief Legal Officer & Corporate Secretary Compensation: $1.39M4 recent tradesDr. Jerh Collins Ph.D. (Age 57)Chief Technical Operations & Quality Officer Mr. Brad Miller (Age 50)Chief Information Officer Ms. Lavina Talukdar CFASenior VP & Head of Investor RelationsColleen HusseySenior Director of Corporate CommunicationsMs. Tracey Franklin (Age 43)Chief Human Resources Officer Dr. Melanie Ivarsson M.B.A.Ph.D., Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Neurocrine Biosciences Insider Trades Bio-Techne Insider Trades Repligen Insider Trades Biogen Insider Trades CRISPR Therapeutics Insider Trades Denali Therapeutics Insider Trades Takeda Pharmaceutical Insider Trades BioNTech Insider Trades Teva Pharmaceutical Industries Insider Trades BeiGene Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MRNA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
